These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Thrombopoietin receptor agonists in refractory immune thrombocytopenia: differential responses to eltrombopag and romiplostim: a case report and possible explanations. Aoki T; Harada Y; Matsubara E; Suzuki T; Oyama T; Kasai M; Uchida T; Ogura M J Clin Pharm Ther; 2012 Dec; 37(6):729-32. PubMed ID: 22583038 [TBL] [Abstract][Full Text] [Related]
7. Romiplostim for the management of pediatric immune thrombocytopenia: drug development and current practice. Neunert CE; Rose MJ Blood Adv; 2019 Jun; 3(12):1907-1915. PubMed ID: 31239245 [TBL] [Abstract][Full Text] [Related]
8. Effect of thrombopoietin receptor agonists on the apoptotic profile of platelets in patients with chronic immune thrombocytopenia. Mitchell WB; Pinheiro MP; Boulad N; Kaplan D; Edison MN; Psaila B; Karpoff M; White MJ; Josefsson EC; Kile BT; Bussel JB Am J Hematol; 2014 Dec; 89(12):E228-34. PubMed ID: 25132654 [TBL] [Abstract][Full Text] [Related]
10. Safety, tolerance, pharmacokinetic and pharmacodynamic properties of thrombopoietin mimetic peptide for injection in Chinese healthy volunteers: a randomized, placebo-controlled, double-blind study. Sheng XY; Liu ZY; Zhao J; Song L; Zhao WM; Zhao X; Cui YM Platelets; 2022 Nov; 33(8):1185-1191. PubMed ID: 35549802 [TBL] [Abstract][Full Text] [Related]
11. Thrombopoietin and thrombopoietin mimetics in the treatment of thrombocytopenia. Kuter DJ Annu Rev Med; 2009; 60():193-206. PubMed ID: 19642221 [TBL] [Abstract][Full Text] [Related]
12. Novel thrombopoietic agents: a review of their use in idiopathic thrombocytopenic purpura. Stasi R; Evangelista ML; Amadori S Drugs; 2008; 68(7):901-12. PubMed ID: 18457458 [TBL] [Abstract][Full Text] [Related]
13. The biology of thrombopoietin and thrombopoietin receptor agonists. Kuter DJ Int J Hematol; 2013 Jul; 98(1):10-23. PubMed ID: 23821332 [TBL] [Abstract][Full Text] [Related]
15. Highly fluctuating thrombocytopenia developing in a patient with immune thrombocytopenia (ITP) while administering romiplostim. Shinohara K; Kambara N Intern Med; 2012; 51(11):1399-401. PubMed ID: 22687850 [TBL] [Abstract][Full Text] [Related]
16. The role of AMG-531 in the treatment of thrombocytopenia in idiopathic thrombocytopenic purpura and myelodysplastic syndromes. Tiu RV; Sekeres MA Expert Opin Biol Ther; 2008 Jul; 8(7):1021-30. PubMed ID: 18549331 [TBL] [Abstract][Full Text] [Related]
17. Thrombopoietin Receptor Agonists in Children with Immune Thrombocytopenia: A New Therapeutic Era. Lassandro G; Palladino V; Vecchio GCD; Palmieri VV; Corallo PC; Faienza MF; Giordano P Endocr Metab Immune Disord Drug Targets; 2021; 21(3):397-406. PubMed ID: 32473624 [TBL] [Abstract][Full Text] [Related]
18. A Review of Romiplostim Mechanism of Action and Clinical Applicability. Bussel JB; Soff G; Balduzzi A; Cooper N; Lawrence T; Semple JW Drug Des Devel Ther; 2021; 15():2243-2268. PubMed ID: 34079225 [TBL] [Abstract][Full Text] [Related]
19. Romiplostim: a review of its use in immune thrombocytopenia. Keating GM Drugs; 2012 Feb; 72(3):415-35. PubMed ID: 22316355 [TBL] [Abstract][Full Text] [Related]
20. Long-term use of the thrombopoietin-mimetic romiplostim in children with severe chronic immune thrombocytopenia (ITP). Bussel JB; Hsieh L; Buchanan GR; Stine K; Kalpatthi R; Gnarra DJ; Ho RH; Nie K; Eisen M Pediatr Blood Cancer; 2015 Feb; 62(2):208-213. PubMed ID: 25345874 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]